ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.
| Website | https://parcelbio.com/ |
| Employees | 7 (5 on RocketReach) |
| Founded | 2024 |
| Address | 135 Mississippi St, San Francisco, California 94107, US |
| Industry | Biotechnology Research |
| Keywords | Mrna Therapeutics, Drug Delivery, Targeted Drug Delivery, Innovative Drug Delivery, Nanoparticle Technology, Advanced Drug Delivery, Biotechnology, Pharmaceutical Technology, Gene Therapy, Rna Therapeutics, Molecular Medicine, Cell Therapy, Precision Medicine, Therapeutic Delivery |
| Competitors | Amazon, FedEx, ShipBob, Easyship, Red Stag Fulfillment, Ware2Go, ShipMonk, Deliverr, Fulfillrite, Descartes ShipRush +35 more (view full list) |
Looking for a particular ParcelBio employee's phone or email?
Christopher Carlson is the Co-Founder and CSO of ParcelBio.
5 people are employed at ParcelBio.
ParcelBio is based in San Francisco, California.